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The three Rat Sarcoma (RAS) genes in humans (HRAS, KRAS, and NRAS) are the most common 
oncogenes that are mutated in human cancer. Mutations that permanently activate RAS are found 
in 20% to 25% of all human tumors and up to 90% in certain types of cancers. For this reason, the 
RAS pathway is being heavily studied, however, there are still many unknowns in regulation and 
downstream effects of RAS in cancer. Previous computational work that focused on signaling in 
the RAS pathway relied mainly on continuous models that use ordinary differential equations or 
reaction rule-based models. These approaches are most often limited in size due to the lack of the 
information required to create such models. In this work, we use a discrete modeling approach, in 
which elements of the intracellular signaling network are modeled as discrete variables, and the 
elements’ regulatory functions are either implemented as logical functions, weighted sums, or 
min/max functions. The network that we are modeling includes a number of intertwined feedback 
and feed-forward loops. We developed several versions of the RAS pathway model, and our results 
demonstrate the advantages of the discrete logical modeling approach when studying intra-cellular 
signaling networks. In addition to model design and analysis, we have worked on developing a 
translator from the biological mechanism representation used by continuous models, into the 
decision tree representation, namely Binary and Algebraic Decision Diagrams. The goal of this 
 v 
translation effort is to allow for a standardized and comprehensive modeling approach, which can 
capture all the available system parameters, while at the same time enabling model design and 
evaluation even in the absence of these parameters.  
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1.0  INTRODUCTION 
The Rat Sarcoma (RAS) gene family are the most commonly mutated genes in human tumors. 
Three elements in this family (HRAS, KRAS, and NRAS) are known to promote cancer 
proliferation and growth in tumors [1]. Mutations in other upstream or downstream components 
of the RAS signaling pathway shown in Figure 1 can also be found in a variety of cancers. The 
mitogen-activated protein kinases (MAPK) – part of the EGFR/RAS/MAPK [8] pathway and 
downstream of the RAS signaling pathway –  increase significantly in activity once there is a 
mutation in the RAS protein [6][7]. KRAS mutations are especially common events in cancer. 
They are detected in 40-45% of all colorectal cancers [2][3] and have been detected in both early 
and late stages of colorectal cancer [4][5], therefore, KRAS mutation might be an early event in 
tumor development.  
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Figure 1 : Ras pathway in a cell, and its upstream and downstream elements [27] 
 
Ras proteins are molecular switches that, by cycling between inactive guanosine 
diphosphate(GDP)-bound and active guanosine triphosphate(GTP)-bound forms, regulate multiple 
cellular signaling pathways, including those that control growth and differentiation. The oscillation 
between inactive and active states is a key feature to regulate cellular growth. The mutation of 
KRAS and its constant activity disrupt this oscillating behavior of the GDP/GTP form, thus leading 
to a growth that is no longer regulated, and the creation of a tumor. Modeling this pathway could 
give critical information about how to regulate the behavior of mutated of a mutated RAS signaling 
pathway to prevent the development of a tumor. 
The computational modeling of intra-cellular signaling pathways such as RAS pathway 
usually includes Ordinary Differential Equations (ODE) that are derived from biochemical 
reactions [10]. Such an approach requires not only listing all the reactions that are involved in the 
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modeled pathway, but also the knowledge of all the reaction rates and molecular concentrations. 
As a result, the ODE-based modeling approach is limited in scale, usually targets only few 
elements on one pathway, and furthermore, the rates of all the reactions are not always known. To 
overcome the problem of exponential growth when modeling biochemical reaction networks, a 
reaction rule-based approach has been proposed and has been used by a number of researchers 
[11][12]. However, the reaction rule-based approach still requires the knowledge of reaction rates 
and molecular concentrations, which are not always known or available.   
In the effort to avoid the problem of limited knowledge, this work uses a discrete, element 
rule-based modeling approach, which also allows to include a much larger number of elements 
without increasing duration or complexity of the simulation when compared to continuous 
modeling. The discrete modeling approach can capture characteristic dynamic behavior such as 
multi-stability, excitation and adaptation behavior. Whereas utilizing incomplete information 
about pathways (which is the case for many intra-cellular pathways) is usually not practical in 
ODE models, it can be dealt with by using indirect causal evidence when building discrete models. 
This work aims to demonstrate how to reduce the complexity and increase the scope of a 
continuous model by translating it into a discrete model, without loss of biological information. 
For this purpose, we will analyze a reaction rule-based model from Kochańczyk et al. [11] and 
translate it into a discrete model, while keeping the important characteristics of their model. We 
developed a method that utilizes Binary and Algebraic Decision Diagrams (BDDs and ADDs) to 
implement both reaction rules and discrete element update rules. We show how to use these data 
structures in the biological context, when modeling intra-cellular networks. Due to the complexity 
of the RAS pathway, and its critical role in cancer development, we demonstrate our approach on 
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this pathway. Therefore, this work introduces a novel element rule-based discrete model of the 
RAS pathway, its upstream regulation and downstream effectors.  
In Section 2.0 , we briefly discuss intra-cellular signaling networks, continuous ODE-based 
and reaction rule-based modeling, as well as the logical and discrete modeling. We also briefly 
describe the BDD data structure. Next, in Section 3.0 , we provide details of our modeling 
methodology to tackle several biological phenomena: spontaneous behavior, oscillations and 
phosphorylation. Then, we will explain in Section 4.0  how to use the data structure of an ADD 
and their application to analyze biological events. Finally, we will show the results obtained for 
the application of this work to the RAS pathway and to what it could lead to in the future. 
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2.0  BACKGROUND 
This work applies methods from electrical and computer engineering to biology. Thus, in this 
section we discuss relevant background information in both domains. We first describe different 
modeling approaches that we use in this work, continuous (reaction rule-based) and discrete logical 
(element rule-based) modeling approach, followed by the discussion on an implementation method 
and data structures that could be used to represent models in both approaches.  
2.1 MODELING INTRA-CELLULAR NETWORKS 
The construction of a model begins with identifying key components of the studied system. Each 
component can be represented as a model element, and for each element, we determine its 
regulators. In Figure 2, we show several examples of intra-cellular networks. There are three main 
types of these networks: 
- Signal transduction networks 
- Metabolic networks 
- Gene regulation networks 
Most often, computational modelers focus only on one network type. Signal transduction 
networks are mainly focused on protein-protein interactions and protein kinases. The proteins 
responsible for detecting a stimulus are called receptors. The ligand will bind to the receptor and 
create a signaling cascade. This cascade results in interactions such as phosphorylation, 
transcription, translation of gene, post-translational changes in proteins. Metabolic networks are 
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directed graphs which contain genes, enzymes and biochemical reactions such as oxidation and 
reduction, the breakdown of glucose or the joining of amino-acids to form a protein. Gene 
regulatory networks can represent genes, mRNAs, protein/protein complexes or cellular processes 
and the interactions between these elements are usually represented as activation, inhibition and 
binding. 
  
 
Figure 2 : Different types of intra-cellular networks. 
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In this work, we incorporate in our models the elements that belong to all three types of 
intra-cellular networks, including receptor activation, receptors’ downstream protein-protein 
interactions that lead to activation of transcription factors and gene regulations, post-translational 
modifications, and metabolic regulations that affect cellular processes such as apoptosis.  
2.1.1 Biological interactions  
In this section, we list the most common biological motifs that we encountered while developing 
models of intra-cellular networks, and we show their computational representation in the form of 
ordinary differential equations. 
• Activation 
An activation of an element can represent two phenomena:  
(a) an increase in element’s amount in the cell  
(b) an increase in element’s activity with respect to other cellular elements it acts upon.  
If element A is activated by element B, this can be represented as: 
𝐵
𝑘
→ 𝐴 
We can also assume that in some cases k may be given to represents the rate at which the 
activation of A by B occurs. The change in element A’s amount/activity with respect to the 
amount/activity of B can then be computed as:  
𝑑[𝐴]
𝑑𝑡
= 𝑘[𝐵] (1) 
Note that we use [X] to represent the amount or activity of element X. 
• Inhibition 
An inhibition of an element can represent two phenomena: 
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(a) a decrease in element’s amount in the cell  
(b) a decrease in element’s activity with respect to other cellular elements it acts upon.  
If element A is inhibited by element B, this can be represented as: 
𝐵 ⊣ 𝐴 
Similar to activation, we can also assume that a k is given that represents the rate at which 
the inhibition of A by B occurs. The change in element A’s amount/activity with respect to 
the amount/activity of B can then be computed as: 
𝑑[𝐴]
𝑑𝑡
= −𝑘[𝐵] (2) 
• Binding/Unbinding 
Molecular binding is an attractive interaction in which two molecules come together to 
form a protein complex. After binding, the two molecules will have different properties 
than they had before. A protein complex can be classified as either a reversible or 
irreversible covalent bond. If the bond is reversible then the reverse action is called 
unbinding. The following equations show a reversible binding between elements A and B 
to form complex D. We can assume that k1 represents the rate at which D unbinds, and k2 
the rate at which A and B bind. 
𝐴 + 𝐵 
𝑘2
→
𝑘1
←
  𝐷 
The changes in amount/activity of elements A, B and D can be computed as:  
𝑑[𝐴]
𝑑𝑡
= 𝑘1[𝐷] − 𝑘2[𝐴][𝐵] (3) 
𝑑[𝐵]
𝑑𝑡
= 𝑘1[𝐷] − 𝑘2[𝐴][𝐵] (4) 
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𝑑[𝐷]
𝑑𝑡
= −𝑘1[𝐷] + 𝑘2[𝐴][𝐵] (5) 
• Phosphorylation 
The addition of a phosphate group to a molecule is called phosphorylation. When 
phosphorylated, the properties and behavior of the element change with respect to the 
unphosphorylated state. For example, it may bind to other molecules at a lower rate, or not 
bind at all. Phosphorylation can be cooperative,  when additional phosphorylation events 
make it easier to phosphorylate, or uncooperative, when additional events make it harder 
to phosphorylate. If element A can be phosphorylated two times, this can be represented 
as: 
𝐴𝑢
2𝑘1
→ 
𝑘2
←
𝐴𝑝
𝑘1
→
2𝑘2
← 
𝐴𝑝𝑝 
We can compute the rate of change of the unphosphorylated Au, the rate of change of the 
phosphorylated Ap, and the rate of change of App that is twice phosphorylated, as follows: 
𝑑[𝐴]𝑢
𝑑𝑡
= −2𝑘1[𝐴]𝑢 + 𝑘2[𝐴]𝑝 (6) 
 
𝑑[𝐴]𝑝
𝑑𝑡
= −𝑘1[𝐴]𝑝 − 𝑘2[𝐴]𝑝 + 2𝑘1[𝐴]𝑢 + 2𝑘2[𝐴]𝑝𝑝 (7) 
𝑑[𝐴]𝑝𝑝
𝑑𝑡
= 𝑘1[𝐴]𝑝 − 2𝑘2[𝐴]𝑝𝑝 (8) 
There are also other types of interactions, as described at the beginning of Section 2.1. In 
this work, we focus mainly on the interactions that we detailed above.  
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2.1.2 Reaction rule-based modeling 
Rule-based modeling is an approach that uses a set of rules to represent reactions. These rules can 
then be translated into Markov chains or differential equations for simulation of the system. To 
establish a rule-based model we need to know the interactions of the model components and have 
information about the kinetic laws. A powerful feature of this type of modeling is the ability to 
include current states and potential bindings for each model element. In the case of 
phosphorylation, this feature allows for easy tracking of every phosphorylation state of an element. 
A widely-used simulator is BioNetGen [16]. The binding reaction is presented in Figure 3. 
 
Figure 3 : Rule representing a binding reaction using BioNetGen Language [13] 
 
 
2.1.3 Logical Modeling 
The biologists often draw networks that they are studying as graphs, like the one shown in Figure 
4, where nodes represent model elements, and edges represent the interactions between elements. 
Besides being directed, the edges also indicate the polarity of regulation, positive (regular arrows 
in Figure 4) or negative (blunt arrows in Figure 4).  
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Figure 4: A toy example of a logical model. ‘+’ represent an OR logical operator, ‘*’ represents AND 
operator, and ‘!’ represents a NOT operator.  
 
Table 1 : Truth table for AND, OR, NOT 
A B A AND B A OR B NOT A 
0 0 0 0 1 
0 1 0 1 1 
1 0 0 1 0 
1 1 1 1 0 
2.2 BINARY AND ALGEBRAIC DECISION DIAGRAMS 
 Binary Decision Diagrams (BDDs) are a data structure that is used to represent a Boolean 
function. Figure 5 shows a binary decision tree without the reductions rules. A solid line represents 
an edge when the variable is high (equals one) and the dotted line represents an edge when the 
variable is low. This representation is useful to analyze the importance of a variable. For example, 
when X=1 and Y=1, the value of Z does not matter and the outcome will always be F=1. 
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Figure 5 : A BDD and a truth table for the function F(X,Y,Z)= !X*!Y*!Z + X*Y + Y*Z 
 
 
This conclusion leads to the second type of a decision tree that is now commonly used as 
a more optimized version of a decision tree: Reduced Order Binary Decision Diagram (ROBDD). 
As discussed above, the diagram can contain useless or redundant nodes that do not carry any 
additional information. Therefore, we can eliminate them to create an ROBDD. The figure below 
shows the ROBDD for the function F declared above. 
 
Figure 6 : Reduced Order Binary Decision Diagram for the example function in Figure 5. 
 
 
Now we can clearly see that when X=1, the value of Y will determine the value of F. Binary 
Decision Diagrams (BDDs – used as a short for ROBDDs) [20][21] have significantly changed 
the landscape of synthesis, formal verification, and testing of digital circuits. BDDs provide an 
efficient and canonical form of representation of those functions. Despite being reduced to the 
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simplest structure, conventional algorithms such as breadth-first search, do not do well on large 
graphs, simply because they process vertices and edges on an individual basis. Several examples 
of successful applications of symbolic graph algorithms in reachability analysis of finite state 
machines have been reported. All these applications are topological; they address problems where 
connectivity is the principal issue. However, a follow-up work [22] introduced a class of 
algorithms for arithmetic symbolic computation, based on a new kind of BDDs called a Multi-
Terminal Binary Decision Diagram (MTBDD), whose main feature is the adoption of multiple 
terminal nodes. One application of these MTBDD are Algebraic Decision Diagram (ADDs), which 
provide an efficient means for representing and performing arithmetic operations on functions 
from a factored Boolean domain to a real-valued range. The ADDs can also be reduced and 
ordered, thus in this work ADD will refer to ROMTBDD. 
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3.0  MODELING BIOLOGICAL EVENTS USING DISCRETE APPROACH 
  
Figure 7 : Flow diagram for our model assembly and analysis methodology. 
 
 
The development and analysis of a discrete model follows the flowchart in Figure 7. Model 
development relies on the approaches discussed in Section 2.1, which are also further expanded in 
our modeling approach, as will be discussed in the following sections. In short, we decide the 
number of discrete values that each element can take and create update rules for all model 
elements.  
Model analysis starts by identifying or designing an analysis scenario, which guides 
initialization of all model elements, external model stimulations, or internal perturbations, and the 
choice of simulation scheme (deterministic or stochastic) [25]. Depending on the simulation 
scheme, one or more elements can be selected simultaneously and updated according to their 
corresponding update rules. The choice of elements to be updated in each simulation step can be 
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either deterministic or random. We obtain simulation traces for all model elements, and in the case 
of random update scheme, we also compute average trace for each element across multiple 
simulation runs. Finally, we plot all or selected element traces to conduct the analysis and guide 
model updates if necessary. 
In this work, we approach model analysis from two different perspectives. In the first case, 
we are using a model from literature, with the goal to reproduce the results of that model using our 
modeling approach, and to compare and contrast modeling approaches. In the second case, we 
focus on new scenarios, not previously explored. For example, we explore the influence of a 
reaction on a pathway, or on the overall model. To do so, we start by turning OFF this particular 
reaction, and if we do not observe any changes in model’s behavior, we use our model and 
simulation results to explain this observation. If the absence of the reaction changes simulation 
result, then we further explore the reasons for the influence of this reaction, and the overall model 
sensitivity to the reaction. 
3.1 DISCRETE APPROACH 
In this work, we extended beyond commonly used Boolean modeling approach, which assumes 
variables that have only 0 and 1 values, to discrete modeling approach. The limited number of 
possible element values in the Boolean modeling approach leads to a lack of precision and can 
even introduce some errors. For example, let us assume that an element C can be activated by 
element A and inhibited by element B. The truth table associated with this regulatory rule is shown 
in Table 2. From left to right, increase in A and B value, from top to bottom increase in C value. 
If the cell is blue, this indicates that the value of C at the next step is minimal (0 in both Boolean 
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and discrete cases), if the cell is green, the value of C at the next step will be intermediate, and if 
the cell is red, the value of C at the next step will be maximal (1 in Boolean and 2 in discrete case). 
Table 2 : Example truth tables: (left) Boolean variable C;  (right) discrete variable with three values. 
C\AB 00 01 10 11 
0     
1     
  
  
 
Table 3 : Percentages comparison of the two cases in Table 2. 
 0-1 0-2 
Decrease 3/8 -> 37.5% 6/27 -> 22.2% 
Stay 4/8 -> 50% 15/27 -> 55.5% 
Increase 1/8 -> 12.5% 6/27 -> 22.2% 
 6/8 -> 75% 9/27 -> 33.3% 
 0/8 -> 0% 9/27 -> 33.3% 
 2/8 -> 25% 9/27 -> 33.3% 
 
 
 
We can quantify the lack of precision and errors introduced when working with 0-1 values versus 
0-2 values, as shown in Table 3. One could encode all discrete model elements with Boolean 
variables only, which would in the case of our example mean that each element A, B and C is 
represented with two Boolean variables (e.g., A is represented with Ahigh and Alow). With the 
Boolean approach and the truth table in Table 2, the equation for Chigh (using the same notation as 
in Section 2.1.3) is: 
Clow*Chigh*(!Alow*!Ahigh*!Blow*!Bhigh + Alow*!Ahigh*!Blow*!Bhigh + Alow*!Ahigh*Blow*!Bhigh + 
Alow*Ahigh*!Blow*!Bhigh + Alow*Ahigh*Blow*!Bhigh + Alow*Ahigh*Blow*Bhigh) + 
Clow*!Chigh*(Alow*!Ahigh*!Blow*!Bhigh + Alow*Ahigh*!Blow*!Bhigh + Alow*Ahigh*Blow*!Bhigh).  
The logic functions become even more complicated if we are representing discrete variables and 
their update functions using the Boolean approach. An increase in the number of regulators leads 
C\AB 00 01 02 10 11 12 20 21 22 
0          
1          
2          
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to a further increase in the complexity of logic rules, and thus, when modeling networks such as 
the RAS signaling network that has more than 200 elements, a development of a more practical 
method is needed. 
In this work, we use algebraic operations instead of Boolean operations. To this end, we 
define a “discrete OR” operation on three-valued variables, e.g., C = A OR B, as shown in the 
truth table in Table 4. 
Table 4 : A truth table for the “discrete OR” operation. 
AB 00 01 02 10 11 12 20 21 22 
C 0 1 2 1 1 2 2 2 2 
 
 
 
The Table 4 shows that the OR operator when using 0-2 can be replaced by the operator 
MAX. The analysis of other Boolean operators allows a similar translation. For example, the 
operator AND can be translated to MIN. 
3.2 SPONTANEOUS INCREASE AND DECREASE 
One key feature that had to be implemented is the spontaneous increase/decrease behavior feature. 
Let us take a simple example of element A activating element B. When element A is present, the 
value of element B is increasing. Now we turn off A with injection of a drug, and therefore, A is 
no longer present. In a real system, B can decrease with a biological event called spontaneous 
decrease. With no presence of an activator, B return to a baseline level. In our modeling approach, 
before the implementation of this feature, B would stay at a high level. This missing feature was 
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the biggest source of error from model simulations, because without this feature, the elements were 
reaching a wrong steady-state. 
3.2.1  Example in the RAS model 
In the RAS model, one example of spontaneous decay is shown with the elements RALA, B and 
EXOC1-8. As can be seen from Figure 8, the only regulations of EXOC1-8 is an activation from 
RALA and RALB.  
 
Figure 8 : A pathway example used to illustrate the spontaneous behavior. 
 
 
The results of simulation for elements RALA, RALB, EXOC2, EXOC3, before extending 
our modeling approach to include the spontaneous behavior, are shown in Figure 9. 
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Figure 9 : Traces of RALA, B and EXOC2,3 without the spontaneous decay implementation. 
 
 
We can observe from Figure 9 that RALA, B is going down and is not present anymore 
after 2000 steps. However, EXOC2,3 which is only activated by RALA, B is still at max level 
after step 2000. As explained in the introduction of this subsection, the behavior of EXOC2,3 is 
not the one we should expect in biology. Thus, the simulation results improve after implementing 
the spontaneous decay, as shown in Figure 10. 
 
 
Figure 10 : Traces of RALA, B and EXOC2,3 with the spontaneous decay implementation. 
 
 
Without implementing the decay the branch of the Ras pathway shown in Figure 8 would 
not be able to oscillate unless we use negative autoregulation on every element. This solution 
would have produced the expected results but would be biologically incorrect. Now, if RALA, B 
oscillates then the elements downstream are going to oscillate too, depending on the duration of 
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time interval where RALA, B stay at level zero, the decay in EXOC2,3 varies. The whole RAS 
pathway has an oscillatory behavior, and therefore, implementing the spontaneous 
increase/decrease to allow for oscillations in the model was critical to accurately capture this 
system behavior. 
3.2.2 Approach to modeling spontaneous increase/decrease 
The solution adopted is to use a counter that starts when the score of an element’s activators 
(inhibitors) is zero. Given that not all reactions happen at the same rate, we can use a parameter to 
specify how many steps to wait before the spontaneous decrease (increase). In the example used 
above, the counter would start when RALA and RALB are equal to 0. If one of the two elements 
are not 0, then the counter will not start. At every step, one element is updated and the counter will 
only increase when the element is picked. For example, if we have 100 elements with a uniform 
probability distribution and we specified 1 step for decay, then we would need an average of 100 
steps for the element’s value to decrease by one. If the number of steps specified is greater than 
one, then the counter will reset if the conditions are not met. Furthermore, if we use a much larger 
network such as the one describe later in 5.3 and shown in Figure 25, which contains 230 elements, 
and the value range is from 0 to 9, when EXOC2 starts to decay it will need 9*230 =2070 steps 
approximately to reach 0.  
The use of the spontaneous increase/decrease feature implies being careful when 
introducing more variable to represent elements such as dimers. The extra variable used to 
represent the dimers will slow down the decay downstream, as it will require the variable 
representing the dimers to be zero before the element downstream can decay whereas the decay 
can start as soon as the element is 0 if not using an extra variable. 
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3.3 OSCILLATIONS 
As stated briefly in the introduction, the behavior of the entire RAS signaling pathway is 
oscillatory. This behavior is mostly due to the activation of EGFR by EGF and its spontaneous 
deactivation. The work from [11] established a correlation between the trace of the concentration 
of EGFR over time and the elements downstream of it. This implies that most of the oscillations 
are due to spontaneous behavior. However, positive or negative feedback from elements 
downstream will change the characteristics of these oscillations such as rising time or amplitude.  
 
Figure 11 : Concentration (moles) of activated RAS, RAF and MEK over time (seconds) 
 
 
3.3.1 Spontaneous behavior 
Once the spontaneous behavior was implemented as described in the previous sections, we can see 
oscillations in the pathway. For example, let us use Figure 12 and remove all the feedback. 
 
Figure 12 : Graph of the feedback in the BioNetGen model [11] 
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With the simplest model containing only activations, and with a manual oscillation of 
EGFR (deactivation at step 150 during 150 steps), the traces of the six elements in Figure 12 are 
the following: 
 
Figure 13 : The trajectories for pathway elements assuming oscillations in EGFR only.  
 
 
With the previous explanation of the spontaneous behavior mechanism and its 
implementation, we analyze the plots in Figure 12, and we can observe the propagation of the 
decay through the signaling pathway.  
3.3.2 Feedbacks 
All the feedbacks presented in Figure 12 have a specific role. The positive feedback from RAS to 
SOS allows for signal amplification. Negative feedbacks emanating from ERK have been 
associated mainly with response attenuation, but negative feedbacks in general may be tackled to 
ensure perfect adaptation or give rise to oscillations [11]. For example, sustained oscillations may 
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arise when a negative feedback loop is embedded within a relatively slow positive feedback loop 
or when a positive feedback loop is embedded within a relatively slow negative feedback loop. 
The time constant of the negative feedback from ERK to SOS is 3e-9, and the positive feedback 
has a time constant of 1e-6 or 1e-7, depending on whether RAS is binding to SOS GTP or SOS 
GDP, respectively. Therefore, in this pathway we have a fast-positive feedback from RAS 
encapsulated in a slower negative feedback from ERK. When using only the feedback in the model, 
without the oscillations in EGFR, we obtain the result shown in Figure 14. 
 
Figure 14 : The trajectories for pathway elements assuming negative feedbacks only. 
 
 
As can be seen from Figure 14, the oscillations in EGFR were not manually enforced, 
however, for elements downstream of EGFR we can still observe oscillations around a mean value 
before they reach steady state. Finally, it is the combination of both the feedback and the 
spontaneous decay due to the oscillation of EGFR that will produce more complex results. 
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3.4 PHOSHPORYLATION 
3.4.1 Phosphorylation in BioNetGen model 
 
Figure 15 : Phosphorylation of SOS by ERK. 
 
 
The model from [11] includes a biological event that is not implemented in our modeling approach. 
This event is the phosphorylation of an element. In Figure 15, we can observe that SOS can be 
phosphorylated up to 4 times and it can only bind to RAS when it is unphosphorylated. Therefore, 
unphosphorylated SOS can be considered as active, whereas phosphorylated SOS (one, two, three 
or four times) can be considered as inactive. Secondly, given the reaction rates q=3e-9s and p=3e-
4s, the speed of the overall reaction is unbalanced as the unphosphorylation happens faster than 
the phosphorylation. Besides, the phosphorylation is not cooperative: when SOS changes from the 
unphosphorylated to the single phosphorylated form, this is happening faster than transforming 
SOS from the 3-phosphorylated to the 4-phosphorylated form. In the translated model, we will use 
delay to represent this difference in the kinetics of phosphorylation. 
3.4.2 Implementation of phosphorylation in discrete modeling 
Our first goal here was to develop a representation for different phosphorylation states of an 
element. So far, one variable was used to represent an element. If its activity was 0, then it is 
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inactive, otherwise it is considered as active. Let us define SOS= {0,1,2,3,4}, the active state of 
SOS is represented as value 4, phosphorylated one time is represented as value 3, phosphorylated 
two times is represented as value 2, phosphorylated once is represented as value 1, and finally, 
unphosphorylated is represented as value 0. Thus, the truth table for RAS, which is activated by 
the binding of SOS unphosphorylated and EGFR active, can be written as shown in Table 5.  
Table 5 : Truth table for RAS 
EGFR SOS RAS 
0 0 0 
0 1 0 
0 2 0 
0 3 0 
0 4 0 
1 0 0 
1 1 0 
1 2 0 
1 3 0 
1 4 1 
 
 
 
Although this method is technically possible, it is not suited for a large model, as it would 
require significant manual (not automated) work. Using more variables is a necessity to represent 
multiple phosphorylation. However, as we stated at the beginning of this thesis, one of the goals 
of our work and the discrete modeling approach is to be able to use abstraction to overcome the 
issues of incomplete or uncertain information. If too many details are introduced then there is no 
advantage to use this method compared to ODEs, except the speed of simulation. Therefore, using 
one variable for each state of an element was ruled out and we introduced two variables to represent 
the different states: One for the inactive/phosphorylated state and one for the 
unphosphorylated/active state. A high activity of the phosphorylated variable would represent a 
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highly phosphorylated state of the element. In Figure 16, we show the behavior of the two variables 
that we introduced to represent different phosphorylation states of SOS. 
 
Figure 16 : Trajectories for the two SOS variables: phosphorylated (left) and unphosphorylated 
(right). 
 
 
As can be seen from Figure 16, we always have a small activity of unphosphorylated SOS 
ready to bind, and the average of phosphorylation for SOS is the 3-phosphorylated state. This result 
was expected due to the rates of the reactions: the unphosphorylation happens faster than the 
phosphorylation, therefore always having a small amount of unphosphorylated SOS is correct.  
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4.0  IMPLEMENTATION OF REACTION RULE-BASED MODELS USING BDD 
AND ADD DATA STRUCTURES  
As explained in Section 3.1, Boolean simulation was extended to discrete simulation thanks to the 
use of mathematical operations to translate Boolean operator. In Section 2.2, we explained the 
structure of an ADD and we saw that it does not have weight on its edges. However, in a biological 
context we can determine whether an element is high/present or low/absent. Therefore, adding a 
probability for each node to be equal to one would be equivalent to include the element activity. 
With this property added to this structure, ADD can now be used in two different ways: first, it 
can translate biological reaction, and second, it can be used to perform short term analysis of a 
node through simulations. 
4.1 REACTION TRANSLATION USING ADDS 
In this section, we will describe our approach to use ADDs to represent the reactions that were 
defined in Section 2.1.1: activation, inhibition, binding/unbinding and phosphorylation. We 
illustrate our approach using small examples with elements A, B, C. 
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Figure 17 : ADD for the (left) Inhibition rule and (right) Activation rule. 
 
 
In Figure 17, we show a simple example of this data structure to represent biological 
reactions. The terminal of the tree represents a change in B activity at the next step: in the left tree, 
A is inhibiting B, therefore, if A is present, the activity of B will decrease at the next step. But this 
structure can be used to represent more complex reaction such as unbinding. From Figure 18, we 
can see that more precision can be achieved on this structure by including a constant rate. In Figure 
18 (left), we illustrate the representation of unbinding without including a rate constant, while in 
Figure 18 (right), we show an ADD with a rate constant of 0.2 for unbinding. Elements A and B 
bind to create element C. Unbinding, which is the reverse reaction, leads to the decomposition of 
C and elements A and B are recovered. So, if C is present, meaning we are looking at the true edge, 
it can unbind. Without the rate constant value in the terminal node, it would mean that all of C is 
unbinding, so it could be applied to single cell modeling. With the rate value, only a portion of C 
is unbinding and the value of C_next is 0.8 instead of 0.  
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Figure 18 : ADD for the Unbinding rule: (left) with rate constant,(right) without rate constant 
 
 
Figure 17 and Figure 18 show how we can use mathematical operations to translate biological 
events. In the case of more complex biological motifs, this structure enables fast translation from 
reaction rule-based approach to element rule-based approach and it also facilitates validation of 
the discrete modeling approach. 
 
4.2 SHORT TERM ANALYSIS 
Additional application of the ADD structure is in model analysis. The implementation of discrete 
or logical models using ADDs is straightforward, and therefore ADDs can speed up the analysis 
of models created using the discrete or logical modeling approach. 
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Figure 19 : Representation of SOS1 update rule using an ADD. 
 
 
With the introduction of probabilities to represent the activity/amount of each variable 
present at a certain step, we can use this structure to determine what behavior will SOS1 have in 
the next step. The update rule of SOS1 is EGFR*EGF + RTK – MAPK3*MAPK1. We use two 
scenarios here. The Scenario 1 contains a high value of RTK which will allow SOS1 to increase. 
The Scenario 2 shows that when RTK is turned down, SOS1 will not have strong enough activators 
to increase. 
Table 6 : Probabilities of elements 
Probability EGFR EGF RTK MAPK3 MAPK1 
Scenario 1 0 0.33 0.7 0.1 0.7 
Scenario 2 0 0.33 0.1 0.1 0.7 
 
 
 
 In Table 6, we present the probabilities for each element in the SOS1 update rule to be 
equal to 1 in the two scenarios. Using these probabilities, an algorithm will compute the probability 
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to reach every final value. Table 7 shows the total probability for every terminal value in the two 
scenarios. If the highest probability is negative, then SOS1 will decrease in the next step. If the 
probability is 0, SOS1 will stay constant, and if the highest probability is positive then SOS1 will 
increase. The yellow cells represent the highest probability computed in the two scenarios. These 
results are confirmed by the simulation traces shown in Figure 20, for Scenario 1 (left) and for 
Scenario 2 (right). 
Table 7 : Total probabilities for every element value. 
Probability -3 -2 -1 0 1 2 3 4 
Scenario 1 0.01407 0.006930 0.132660 0.168610 0.026730 0.462000 0.189000 0 
Scenario 2 0.042210 0.020790 0.397980 0.365830 0.080190 0.066000 0.027000 0 
 
 
 
 
Figure 20 : Traces of SOS 1 in Scenario 1 (left) and Scenario 2 (right). 
 
 
These examples show that this method is yet limited to short term analysis because once a 
feedback occurs (around 500 steps in Scenario 1), then SOS1 starts to decay, and the probability 
of decay is not high enough. Finally, since the ADD structure is automatically reduced, we can 
aim to use this structure to find simplification in update rules. 
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5.0  MODELING OF RAS PATHWAY IN CANCER CELL 
To model the RAS pathway, we used different paper and data with different aim. So far, four 
models were used:  
(1) A reaction rule-based model written using the BioNetGen language [11], which reproduced 
oscillations observed in MAPK signaling pathway, but is lacking the dimerization of RAFs.  
(2) A model translated from (1) into our discrete modeling approach to determine if our 
approach can capture the pathway characteristics.  
(3) An extended version of the model in (2) that includes more elements than the model in (2) 
to evaluate the impact of a bigger scale network.  
(4) A model created using our discrete modeling approach, following a graph from [24].  
The last model listed was the first model created in this work, however, the graph from [24] is 
unclear, leading to uncertainties. Therefore, to unveil some of these uncertainties, the use of 
literature and previous modeling work was needed. The analysis of the BioNetGen model, 
targeting only the key elements of this pathway, helped to get a better comprehension of this 
signaling pathway. 
5.1 REACTION RULE-BASED MODEL OF RAS PATHWAY 
We decided to investigate the model from [11], that is, to start from this smaller model of a single 
pathway, and then expand it later to include other pathways, instead of trying to validate a large 
model with more than a thousand element interactions. The reaction rule-based model from [11] 
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is using numerical solution of ODEs to determine the concentrations of every element in the model. 
As discussed earlier in this thesis, such approach can ideally provide precise numerical values but 
it requires a lot of knowledge. For example, this detailed approach describes the mechanisms of 
reactions at the beginning of the pathway, however, the dimerization of RAFs, which are activating 
the elements downstream from Ras, is not included due to the lack of knowledge about this 
mechanism. Therefore, this model would not be useful to test hypothesis about RAFs. However, 
when looking at the rules, we can extract a few characteristics that could be relevant for the other 
models.  
Besides the simplification of RAF’s mechanism, another downside of this model is its poor 
extensibility. As stated in the introduction, continuous models need a lot of information that is not 
all available for this pathway. The objective of our work is to model the entire network that 
includes not only the pathway shown in Figure 12, but also other key regulators of this pathway, 
as well as its downstream effectors. The interaction map of this network is shown in Figure 25, 
and is adopted from [24]. Furthermore, we are interested in including RAF dimerization, given 
that the previous work investigating this mechanism has shown interesting behavior on the 
pathway [26],  and our goal is to reproduce this behavior in simulations. That implementation was 
not possible using the reaction rule-based modeling, while we were able to implement it using the 
discrete modeling approach.  
 
Figure 21 : Concentration (moles) over time (seconds) of RAS, RAF and MEK. 
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In Figure 21, we show results for RAS, RAF and MEK, obtained from the model in [11], 
using BioNetGen tools [16]. Two important conclusions can be drawn from this graph. First, we 
can see that the amplitude of the peak is different for every element (Only RAS, RAF and MEK 
are included for a better visibility) with the concentration of active RAF, twice superior than the 
concentration of active RAS, but RAS and MEK have the same magnitude. The other characteristic 
is the speed of the signaling pathway, which is rapid, as we can barely distinguish the time for the 
peak of RAS (the most upstream of the signaling pathway between these three elements), and the 
peak of MEK (the most downstream in the pathway). Therefore, every model that does not show 
these two characteristics needs to be refined. 
5.2 TRANSLATED MODEL FROM BIONETGEN TO DISCRETE VARIABLES 
After finalizing the analysis of the previous model, we created a discrete model based on it. The 
creation of this discrete model, and the corresponding analysis have been beneficial in the process 
of understanding and improving the discrete modeling approach. We have developed a method to 
achieve oscillations when using one variable per element vs. multiple variables per element, and a 
method to incorporate into the model the delay and spontaneous increase/decay in order to 
reproduce the cooperative/uncooperative behavior of the reactions.  
In the BioNetGen model, EGFR is oscillating between active and inactive state, with a fast 
increase to a high concentration (almost instantaneous), a brief time at the highest concentration 
and then decaying, so active EGFR is present approximately 25% of the duty cycle. By adding a 
toggle feature on our simulator, we can simulate pulse of active EGFR with the frequency that we 
desire. When testing different scenarios, the result is that the oscillation of EGFR is necessary for 
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the entire pathway to oscillate, and the speed of this oscillation determines the speed of the 
oscillations in the pathway: Even when slowing down the reactions of other elements, such as the 
dephosphorylation of SOS, the cycle between RAS-GDP (inactive) and RAS-GTP (active) seems 
to be determined by EGFR. 
 
Figure 22 : Activity of RAS_GTP with active EGFR 80% duty cycle. 
 
 
As can be seen from the simulation results shown in Figure 22, if EGFR activity is not 
zero, we observe a medium activity level of active RAS. When EGFR is removed, we have this 
fast decay and active RAS is dropping down to 10%. This shows that a high activity of EGFR is 
not required to activate RAS. Since high EGFR is not required, our signal was equivalent to 80% 
active and 20% inactive which is the opposite of the model in Section 5.1. Therefore, EGFR signal 
was modified to 200 steps inactive, 50 steps active, which is equivalent to 80% inactive  and 20% 
active.  
 
Figure 23 : New EGFR signal, and the RAS response. 
 
 
We can observe from Figure 23 that the behavior of active RAS is the one expected, as it 
is almost 0 when EGFR is not present. To accentuate the peak waveform, the only parameter to 
play with is the delay, which is closely related to the kinetics of the reactions. These constants 
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were defined in the rule-based model and were used in our discrete approach to increase the 
number of steps required for a change in an element’s value. The results below are even closer to 
the real observed behavior because RAS does not stay at a steady low level for an extended time. 
RAS is rising fast and then decaying like in the model in Section Error! Reference source not f
ound.. We also observe in Figure 23 that the RAS activity stagnates for a couple of steps before 
decaying, and that the RAS magnitude is increased. 
 
Figure 24 : The same EGFR signal as in Figure 23, with increased delay in the model. 
 
 
We can conclude from the discussion in this section and the results, that the characteristics 
of the model described in Section Error! Reference source not found., which uses ODEs, were s
uccessfully reproduced using a discrete model. However, this required a lot of manual work and 
analysis. Therefore, our goal is to develop a unique representation for biological events that we 
described in Section 2.1.1, that can accurately incorporate these mechanistic events into a discrete 
model. A promising data structure that allows us to develop such representation are binary decision 
diagrams. 
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5.3 MAIN MODEL 
The main model that we created in this work was developed following the interaction map shown 
in Figure 25.  
 
Figure 25 : Graph used to create our main model [24]  
 
 
The first step in the development of this larger model was to determine the correct 
interpretation for a number of interactions shown in the graph in Figure 25, which contains many 
uncertain connections. We had to make a number of assumptions when developing element-based 
rules for the model. For example, MAPK1,3 is joining PEBP1 to inhibit ARAF, BRAF and RAF1. 
This edge can have different interpretations: It could be represented as an AND relation between 
MAPK1,3 and PEBP1, which means that both elements need to be active to inhibits every RAF. 
However, we found out that PEBP1 is targeting only RAF1 and that the relation between 
MAPK1,3 and PEBP1 is an OR relation. Additionally, we can use the available databases, such as 
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Universal Protein Resource (UniProt) [5], which is a freely accessible database of protein 
sequences and functional information, to check the interactions between some elements. As our 
first approach, and due to the fact that the graph contains 229 elements, we tried to reduce the size 
of the model by grouping the elements that seemed redundant. For example, SHC1-4 have the 
same relations (activating RASs), such that they could be gathered into a single variable SHC. 
However, expression level data from the FNLCR (see Table 8) containing information about every 
element in this pathway shows that even if some elements are from the same family, they are not 
acting the same way and might not have the same activity. The column 1 is the expression of the 
gene in the normal and tumor case. The column 2 shows the value assigned to the variable in the 
normal case when using three levels. The column 3 shows the value assigned to the variable in the 
normal case when the range of values for each element is from 0 to 9. The data range in column 1 
is from 0 to 16, and given that we are using 0,1 and 2 in the model, we defined thresholds in the 
data, such that every element with a value between 0 and 5.3 will be 0 in our simulator, between 
5.33 and 10.66 will be 1 and from 10.66 to 16 will be a 2. SHC1-2 will be declared as 2 and SHC3-
4 will be declared as 0. Therefore, lumping together the SHC1-4 into a single variable SHC and 
initializing it to 0, 1 or 2 would mean that we are introducing 2, 4 or 2 errors, respectively. This 
data shows that we need to keep each element separated but also that using more levels could give 
more precision. Looking at column 4, the initial value for SHC3 is still 0 but for SHC4 is now 1.  
Table 8 : Expression level of SHC1-4 and their initialization 
 Normal Initial Value 0-2 Initial Value 0-9 
SHC1 11.32276 2 7 
SHC2 11.0359 2 7 
SHC3 0 0 0 
SHC4 1.6896 0 1 
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When initializing an intermediate model element (that has both upstream and downstream 
elements), this difference will not have a significant impact on the result. But an input element of 
this pathway such as CBL being declared as 0 instead of 1 could lead to different results because 
CBL value will not change during the simulation. Due to the large size of this model, a significant 
number of elements have a different initial value when using the wider range. These differences 
will lead to a better precision on the simulation results. 
In the special case of discrete modeling, when we use only Boolean variables and logic 
operations to compute update rules, a problem of scalability appeared. We were not able to create 
the update rules for elements that have a lot of regulators, and with the computer used to run these 
simulations, having 13 regulators was the limit before exceeding memory allocated. This problem 
occurred on many elements and some of them are key elements in the pathway. An example is 
shown in Figure 26, where SOS1, SOS2, GRB2 and SHC1,2,3,4 will all have 15 regulators. 
 
Figure 26 : SOS1, SOS2, GRB2 and SHC1-4 creating a complex [24] 
 
 
Since all the edges are activating edges, we could can assume a smaller number of inputs 
in the influence set of SOS, while still obtaining correct results. In this specific case, that is a 
possible solution. When applied to the whole pathway, the file containing the rules with a 
maximum of 13 regulators for every update rule is 630 megabytes (MB). An order of comparison 
is the previous model with gathered elements weighted 28MB and was running in 1 hour and 30 
minutes approximately when repeating the simulation 200 times, with 2000 steps in each 
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simulation run. This model is 22 times bigger, and therefore, the simulation time would be 22 
times longer, and we could expect it to run in 33 hours. One of the advantages of simulation is that 
we do not have to solve ODEs, and thus, the computational cost is smaller, and it is faster than 
continuous model. To this end, in order to reach the limits of 13 regulators to reduce the size of 
the model, but still obtain correct simulations results and speed up the running time, one solution 
that we considered is to use intermediate variables to compute the expression which allows us to 
easily reduce the size of the model by 99%. With that technique, we managed to reduce the 
computational time from 1 hour and 30 minutes to 2 minutes for 200 runs and 2000 steps. 
In Figure 27, using a toy example, we illustrate our method to reduce the number of 
regulators for elements that have large number of regulators. First, we group the regulators for a 
given element into pairs (Step 2 in the figure). This will divide by two the number of element in 
an update rule, while all the regulations are still included in the model. If after this first step, the 
number of regulators was still high (more than six), then the pairs would be paired into an 
intermediate variable in the next layer (Step 3 in the figure). The computational cost of a node is 
S^N with S the number of possible values and N the number of regulators (positive or negative).  
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Figure 27 : The method to introduce intermediate variables. 
 
 
Table 9. Computational cost with S=3 
Step Formula Computational Cost 
1 3^8 6 561 
2 3*3^2 + 3^3 54 
3 5*3^2 45 
  
 
 
Table 10. Computational cost with S=10 
Step Formula Computational Cost 
1 10^8 100 000 000 
2 3*10^2 + 10^3 1300 
3 5*10^2 500 
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In Table 9, we use three values for every element, and the gain is 99.31%. In Table 10, 
where 10 values are possible for every element, the gain is 99.99% in the second, which means 
that if the original node took 100 seconds to run, on step 3 it will take 0.1s to run. 
By including new variables one can change the behavior of the system and add delays. 
Opposite to delays, we can use the grouped update scheme of the simulator [25], with all 
intermediate variables to speed up the activation of these variable and reduce the delay. However, 
it is more complicated to reproduce the experimentally observed behavior in the latter case, 
because gathering variables together implies making sure that the sensitivity of the update rule to 
each variable is not changing. To study the sensitivity, we run different simulations using different 
initial values of regulators, and we can observe if a different initial state leads to a different steady 
state. However, at what value should the intermediate variables start? It is not always 
straightforward to determine all initial values for model elements. The goal is to see if we can gain 
simulation time while getting the same simulation results. To do so, we created a toy model (Figure 
28) and decided to take an element from the model, its tier one and tier two regulators. The blue 
arrows represent element’s activation and the yellow arrows represent its inhibition. 
 
Figure 28 : Example of how an element can be studied with respect to its regulators. 
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Figure 29 : Influence sets with positive and negative regulators for elements in Figure 28. 
 
 
Here, the tier one regulators are F, H and G. The tier two regulators are A, B, C, D and E. 
L is a tier three regulator, and therefore, will not be included. The first element we decided to study 
is the complex created by MTOR, RPTOR and MLST8, and the result are shown in Table 11. 
 
 
 
Table 11. Comparison of RPTOR rules 
Original Model   
RPTOR (RHEB, RPTOR, MLST8) (PRKAA1, PRKAA2, PRKAB1, PRKAB2, 
PRKAG1, PRKAG2, PRKAG3, RPTOR, 
MLST8) 
Decomposed model   
RPTOR (RHEB, MTOR, MLST8) (PRKA, PRKB, PRKAG3, MTOR, 
MLST8) 
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Figure 30 : Results for RPTOR using the regulator lumping approach. 
 
 
The best results were obtained by initializing the intermediate variable to 0. As foreseen 
earlier, this solution created a delay. That is why the amplitude of the rise is bigger and the decay 
is slower. However, these results still show the same behavior, in terms of rise and decay, and the 
change did not affect the steady state result.  
Table 12. Truth table for an AND gate. C=A AND B 
A B C 
0 0 0 
0 1 0 
1 1 1 
1 0 0 
 
 
 
Another approach to speed up simulations is to just use discrete variables and common 
algebraic operations instead of Boolean operations. For example, if we define C = A AND B (truth 
table shown in Table 12), we can obtain the same result by using the function MIN(A,B). Doing 
these mathematical operations on discrete values is much faster than comparing Boolean states, 
and thus, all the Boolean operators can be translated into mathematical functions. The DiSH 
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simulator [25] that we have been using supports these mathematical operations, by computing the 
total value of the positive activators and the total value of the negative activators, and If the positive 
score is higher, then the element value will increase, but if the negative score is higher, then the 
element value will decrease. 
5.3.1 Modeling results 
We have thus far developed multiple versions of the extended model, and we keep improving it. 
This is an iterative process that requires regular discussions with biologists. For example, one of 
the first simulation results we obtained for the extended model is shown in Figure 31. 
 
Figure 31 : Activity of HRAS, RAF1 and MAP2K2 before removal of CNKSR 
 
 
When EGFR is oscillating, we are expecting the oscillations to propagate down the 
pathway. However, what we can observe from Figure 31 is that RAF1 is barely oscillating with 
one decay at the beginning then a high activity steady state level, and MAP2K2 (also referred to 
as MEK) is reaching its steady state at the beginning of the simulation. In the discussion with 
expert biologists, we determined that some element declared as activators for RAF1 and MAP2K2 
were not supposed to act this way. KSR1,2 and CNKSR1,2 were used as direct activators of RAF1 
and MAP2K2 but instead of activating the element, they are creating a scaffold. This means that 
they are necessary for an activation to happen, but not sufficient for this reaction to take place. 
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When applying this modification, we obtained a new set of results, a few of which are shown in 
Figure 32. 
 
Figure 32 : Traces of HRAS, RAF1 and MAP2K2 after the new feedback from experts. 
 
 
After a number of iterations, and many discussions with experts, and with the implementations of 
several new features in our modeling approach, the extended RAS pathway model that we have 
developed contains more biological motifs than the continuous model found in literature, while it 
also can reproduce results of specific scenarios such as the use of V600E BRAF and its role in 
dimerization [26]. These results are promising and can allow biologist to ask for precise scenario 
and study the response of the RAS pathway in these scenarios. 
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6.0  CONCLUSION 
By combining continuous and discrete modeling, this work aims to improve the precision of 
discrete modeling, in general, and of the RAS pathway model, in particular. First, we showed how 
to move from Boolean to discrete modeling and the implementation of several new features in the 
discrete modeling approach to allow for more accurate results when using this approach. Then, we 
showed a novel analysis method by using the ADD structure to translate biochemical reactions 
and to analyze update rules. Finally, we applied the previous work to successfully translate a 
continuous rule-based model into a discrete model without loss of biological information. Thus, 
we created the first large scale accurate model of the RAS pathway. An important next step for 
this work is to include the study of the scalability of the use of ADDs to represent more complex 
reactions and update rules. Another extension would include the improvements of the RAS model 
using recent published work and data. 
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